Health Care & Life Sciences » Biotechnology | Tiziana Life Sciences PLC

Tiziana Life Sciences PLC

Tiziana Life Sciences PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP92.8 M
Shares Outstanding
126.93 M
Public Float
55.41 M

Profile

Address
55 Park Lane
London Greater London W1K 1NA
United Kingdom
Employees -
Website http://www.tizianalifesciences.com
Updated 07/08/2019
Tiziana Life Sciences Plc operates as a clinical stage biotechnology company that focuses on the discovery and development of drugs that treat human disease in oncology and immunology. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. .

Financials

View All
Created with Highcharts 5.0.14Tiziana Life Sciences PLCNet Income. Fiscal year is January-December. All values GBP Thousands.2832833 3273 3278 6328 6327 2087 2086 7706 7705 9955 99520132014201520162017201802k4k6k8k10k
Created with Highcharts 5.0.14Tiziana Life Sciences PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.3300000000121220132014201520162017201802.557.51012.515

Gabriele Marco Antonio Cerrone
Executive Chairman
Kunwar Shailubhai
Director, Chief Executive & Scientific Officer